EP1290000A4

EP1290000A4 - Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same

Info

Publication number: EP1290000A4
Application number: EP01937449A
Authority: EP
Inventors: Mingqian He; Thomas M Leslie
Original assignee: Corning Inc
Current assignee: Corning Inc
Priority date: 2000-06-16
Filing date: 2001-05-16
Publication date: 2005-07-20
Also published as: CN1425018A; CA2411963A1; WO2001098310A1; AU2001263187A1; EP1290000A1; JP2004501159A

Abstract

The present invention is directed to chromophores having novel electron withdrawing groups and novel bivalent cyclic bridges and to optical waveguides and optical devices having polymeric thin films which contain the novel chromophores.

Description

NOVEL CHROMOPHORES FOR POLYMERIC THIN FILMS AND OPTICAL WAVEGUIDES AND DEVICES COMPRISING THE SAME

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to, and the benefit of, US Patent Application

09/595,221 filed June 16, 2000 entitled "Novel Chromophores For Polymeric Thin Films And Optical Waveguides And Devices Comprising The Same," and US Patent Application 09/675,966 filed September 29, 2000 entitled "Novel Chromophores For Polymeric Thin Films And Optical Waveguides And Devices Comprising The Same." FIELD OF THE INVENTION

The present invention relates to chromophores which can be used in the preparation of polymeric thin films for waveguide media, and to optical waveguides and devices comprising the chromophores. BACKGROUND OF THE INVENTION

Thin films of organic or polymeric materials with large second order nonlinearities in combination with silicon-based electronic circuitry can be used in systems for laser modulation and deflection, information control in optical circuitry, as well as in numerous other waveguide applications. In addition, novel processes through third order nonlinearity such as degenerate four-wave mixing, whereby real-time processing of optical fields occurs, have utility in such diverse fields as optical communications and integrated circuit fabrication. The utility of organic materials with large second order and third order nonlinearities for very high frequency application contrasts with the bandwidth limitations of conventional inorganic electrooptic materials currently in use.

Numerous optically responsive monomers and polymers have been developed for use in organic materials which, in turn, can be used in the waveguide applications described above. For example, U.S. Patent No. 5,044,725, which is incorporated herein by reference in its entirety, describes numerous polymer compositions which provide suitable nonlinear optical response. U.S. Patent No. 5,044,725 describes, for example, a preferred polymer composition comprising an organic chromophore containing an electron donating group and an electron withdrawing group at opposing termini of a bridge.

Synthesis of high performance organic, high μβ electro-optic chromophores must be accomplished in order to make polymer-based electro-optic waveguides and devices. The synthesis of electro-optic chromophore bridge compounds and donor-bridge compounds for organic nonlinear optical applications are generally known in the art. Although some chromophores have been reported in the literature, many of them have shown several and sometimes severe problems ranging from thermal instability, insolubility in the polymer, photodegradability, exhibition of a broad absorption band into the wavelength region of interest, and large birefringence upon poling.

Most recently, U.S. Patent No. 6,067,186 (the '186 patent), disclosed a class of organic chromophores which can result in hardened electro-optic polymers suitable for electro-optic modulators and other devices such as optical switch.

There continues to be a need for suitable electro-optic chromophores with improved properties. SUMMARY OF THE INVENTION

The present invention is directed, in part, to compounds which can serve as chromophores in, for example, thin films for optical waveguides and optical devices. These are compounds represented by Formula I :

wherein:

D is an electron donating group; B comprises at least one bivalent ring; and

R² and R³ each, independently, are selected from the group consisting of substituted or unsubstituted C₂-Cιo alkenyl, substituted or unsubstituted C₂- o alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH₂)_n where n is 1-10. Alternatively, R² and R³ can be selected from substituted or unsubstituted -Cio alkyl, provided that when R² and R³ are both selected from substituted or unsubstituted C_-Cι₀ alkyl the following condition

is also met: R² ≠ R³. More preferably, chromophores of the invention have Formula I' :

where:

R² and R³ are further characterized in that they define a ring in which * denotes a spiro junction, or where * denotes a chiral center; or R² and R³ each, independently, are either, substituted or unsubstituted - o alkyl, substituted or unsubstituted C₂- ₀ alkenyl, substituted or unsubstituted C - o alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocyclic, substituted or unsubstituted heterocyclic, substituted or unsubstituted cyclohexyl, or (CH2)n-O-(CH₂)_n. where n is 1-10. D and B have the definitions given above. In still another aspect of the invention, the chromophores comprise novel cyclic bridges comprising at least one bivalent aromatic ring. Preferred compounds of the invention have Formula II:

wherein D is an electron donating group; A is an electron withdrawing group; K is O or S; R¹ is -Q-C„H_2n+ι, -Q-(CH₂)_aC_nF_2n+ι, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC_nF₂n₊ι. -Q- CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; and q is 1, 2, or 3.

Other preferred compounds of the invention have Formula III:

wherein D is an electron donating group; A is an electron withdrawing group; J is CH₂, O or S; R¹ is -Q-C_nH_2n+ι, -Q-(CH₂)_aC„F_2n+ι, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC„F_2n+1,

-Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S.

In other embodiments of the invention, the chromophores comprise novel cyclic bridges comprising at least one bivalent or conjugated ring structure, such as an aromatic ring, and novel electron withdrawing groups. Such compounds are generally represented by the structure of Formula IN:

wherein D is an electron donating group; K is O or S; R is -Q-C_nH_2n+1, -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C_nF_2n+ι, -Q-CH₂SCH₂CC_nF_2n+ι, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; q is 1, 2, or 3; and R² and R³ each, independently, are either substituted or unsubstituted Cι-C₁₀ alkyl, substituted or unsubstituted C₂-C₁₀ alkenyl, substituted or unsubstituted C₂-Cι₀ alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, or (CH₂)_n-O-(CH₂)_n where n is 1-10. Alternatively, R² and R³ together form a ring structure or a substituted ring structure. Preferred compounds of this embodiment are represented by the structure of Formula IV:

(IN') where:

R and R are further characterized in that they define a ring in which * denotes a spiro junction, or where * denotes a chiral center. Other useful compounds of the invention have Formula N:

wherein D is an electron donating group; J is CH₂, O or S; R¹ is -Q-C_nH_2n+ι. -Q- (CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC_nF_2n+], -Q-CH₂OCH₂CF₃, or -Q- CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; and R² and R³ each, independently, are either H, substituted or unsubstituted Cι-Cι₀ alkyl, substituted or unsubstituted C₂-Cι₀ alkenyl, substituted or unsubstituted C₂-Cι₀ alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, or (CH₂)_n-O-(CH₂)_n where n is 1-10. Alternatively, R² and R³ together form a ring structure or a substituted ring structure. Preferred chromophores of this embodiment include compounds of Formula (V ) :

(V ) where:

R² and R³ are further characterized in that they define a ring in which * denotes a spiro junction, or where * denotes a chiral center.

The present invention is also directed to optical waveguides comprising a thin film medium having Formula VI:

VI

wherein P and P' are polymer main chain units, which can be the same mer unit or different mer unit, and C is a comonomer unit where n is an integer greater than zero and n' is 0 or an integer greater than zero; S is a pendant spacer group having a linear chain length of between about 2-12 atoms. M is a compound having either Formula I, Formula F, Formula II, Formula III, Formula IN, Formula IV, Formula N, or Formula V, as described above. The phrase "electron donating group" is used synonymously with "electron donator" and refers to substituents which contribute electron density to the π-electron system when the conjugated electron structure is polarized by the input of electromagnetic energy.

The phrase "electron withdrawing group" is used synonymously with "electron accepting group" and "electron acceptor" and refers to electronegative organic compounds or substituents which attract electron density from the π-electron system when the conjugated electron structure is polarized by the input of electromagnetic energy.

The term "chromophore" as used herein refers to an optical compound comprising an electron donating group and an electron withdrawing group at opposing termini of a conjugated π-electron system.

The phrase "cyclic bridge" is used to refer to bivalent cyclic structures which serve to couple the electron donating and withdrawing groups.

The present invention is also directed to optical devices comprising the optical waveguides described above.

DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION

The present invention is directed, in part, to novel electro-optic chromophores which have utility in organic nonlinear optical applications such as polymeric thin films for optical waveguides and optical devices. Such polymeric thin films are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety.

The inventive chromophores have several advantageous features which are not found in other known or commercially available chromophores. For example, we have found that the introduction of a chiral center, preferably in the acceptor portion of the molecule, and more preferably as a racemic mixture, greatly increases the chromophore' s solubility. We have found that solubility is enhanced the greater the structural or functional differences between R² and R³. For example, we have observed significantly enhanced solubility when one of R² or R³ is a chain and the other is a ring structure; or when one is a short chain (up to three carbons), and the other is a long chain (say, C4- C18). This increased solublility in turn can lead to an enhanced nonlinearity of the final material in many cases. It is known that the introduction of long chain alkane groups increase the solubility of chromophores, and that as the number and size of the alkane moieties increase, both the solubility and bulk material nonlinearity are greatly improved. The chromophores of the present invention have an enhanced solubility over the dimethyl types of the prior art.

While there may be other factors contributing to this improved property, we have found that one major difference between the inventive acceptors and those of the prior art is the presence of chiral centers in the inventive acceptors. It is known that the physical characteristics like melting point and solubility are different for the pure enantiomer than for the racemic mixture. Several examples of this difference exist. For example, pure chiral (D) lycine has a melting point of 218 C and is very soluble at room temperature. The racimate has a melting point of 170 C and is considered infinitely soluble in room temperature water. Also, pure enantiomers of Mandelic acid have a melting point of 133 C while the racimate has a melting pint of 120 C. (R )-(+)-Mandelonirile has a melting point of 29 C while the racimate is an oil at room temperature.

In the specific chemistry of the present invention, the chiral centers do not form a single chiral compound but rather a mixture of racemic enantiomers, which when introduced into chromophores increase the solubility of the chromophores due to a depression of the melting point. In fact, we have found that the inventive compounds tend to form glassy solids rather than crystalline materials. Without intending to be bound by theory, we believe that the present chemistry results in improvements in the nonlinearity of the bulk polymer because of the incorporation of a racemic chiral center in the chromophores.

The electro-optic chromophores of the invention exhibit thermal stability to temperatures from 260 C to 310 C. These chromophores also show great solubility in most common organic solvents and, thus, are useful when used as a guest additive in most polymer films for waveguides. In addition, under intense UV-irradiation (365 nm, dosage 3 J/cm² up to 13 minutes), the chromophores of the invention show no changes of the UN- NIS-ΝIR spectrum, which indicates that the chromophores are photostable. The chromophores also demonstrate an adjustable absorption band away from normal communications wavelengths, which can be very important for reducing optical loss at communication wavelengths. The chromophores of the invention have significant three- dimensional design which can prevent chromophore-chromophore anti-parallel stacking. Because of the flexible side chain substitutions, the chromophores of the invention show significantly reduced birefringence losses. In some of the chromophores of the invention, there is unique regiospecific substitution on the bridging thiophene ring, which allows the electron acceptor to more easily access the conjugated π-system of the bridge and allows the molecule backbone to be flatter. In addition, some of the preferred chromophores of the invention have hydroxyl groups on the electron donor termini in order to easily process the chromophore into hydroxyl compatible organic and inorganic polymer reactions to make soluble chromophores, polymers and copolymers, as well as can be used to make highly soluble "guest" chromophores for guest-host applications.

The present invention is directed, in part, to compounds which can be employed as chromophores in polymeric thin films for optical waveguides. In preferred embodiments of the invention, such compounds comprise novel electron withdrawing groups having Formula I:

where: D is an electron donating group. Preferred electron donating groups are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety. Preferably, D is selected from the group consisting of, but not limited to, phenyl ring(s) substituted in the para position by, for example, amino, alkylamino, dialkylamino, dialkylanilino, 1-piperidino, 1-piperazino, 1-pyrrolidino, acylamino, hydroxyl, thiolo, alkylthio, arylthio, alkoxy, aryloxy, acyloxy, alkyl, vinyl, 1,2,3,4-tetrahydroquinolinyl, and the like. The most preferred electron donating groups are substituted and unsubstituted -

phenyl-N(CH₂CH₂OH)₂.

B is a cyclic bridge which couples the electron withdrawing group and the electron donating group. Preferably, B is at least one bivalent ring. Preferred cyclic bridges comprise one or a plurality of bivalent rings. Preferred bivalent rings which can be employed as cyclic bridges in the present application are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety. Ring B can be aromatic or non- aromatic. Preferably, B is selected from the group consisting of, but not limited to,

where R⁴ is H, OH, Cι-Cι₀ alkyl, alkenyl, or alkynyl, halogen, and the like. R⁴ can also be -Q-C_nH_2n+ι, -Q-(CH₂)_aC_nF_2n+ι, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC_nF_2n+ι, -Q- CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; and q is 1, 2, or 3.

R² and R³ each, independently, are selected from the group consisting of, but not limited to, substituted or unsubstituted Ci-Cio alkyl, substituted or unsubstituted C₂-Cι₀ alkenyl, substituted or unsubstituted C₂-Cι₀ alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, (CH₂)_n-O-(CH₂)_n where n is 1-10, and the like. " -Cio" refers to C C₂, C₃, C₄, C₅, C₆, C₇, C₈, C₉, C₁₀, and all combinations of ranges thereof. Preferably, when R² and R³ are both selected from

substituted or unsubstituted Cι-Cι₀ alkyl the following condition is also met: R² ≠ R³. More preferably, R and R define a ring in which * denotes a spiro junction, or where * denotes a chiral center.

The substituted alkyl, alkenyl, alkynyl, carbocyclic, and heterocyclic groups can comprise one or a plurality of substituents including, for example, fluorine, chlorine, D, and the like. In addition, the heterocyclic groups can comprise O, N, S, and the like.

The aryl groups preferably include, but are not limited to, benzyl, phenyl, fluorenyl, and naphthyl. The aryl groups, carbocycles, heterocycles, and cyclohexyl can also be substituted by one or a plurality of substituents including, for example, D, halides, including fluorine, chlorine and bromine. The alkylaryl groups preferably comprise - o alkyl and the substituted alkylaryl groups comprise the substitutions for the alkyl and aryl groups described above.

In more preferred embodiments of the invention, R² and R³ each, independently, are selected from the group consisting of benzyl, carbocycle, heterocycle, cyclohexyl, phenyl, cycloalkyl, cycloalkenyl, and substituted phenyl. Additional moieties for R² and/or R³, independently, include, but are not limited to the following:

and the like. In even more preferred embodiments of the invention, one of R² and R³ is CH₃ and the other of R² and R³ is a substituted phenyl. Preferably, the substituted phenyl is selected from the group consisting of, but not limited to:

and the like.

Alternatively, R and R together form a ring ^' structure or a substituted ring structure from 3 to 7 atoms total with 5 or 6 atoms being preferred. Preferably, the ring structure is substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, or substituted or unsubstituted cyclohexyl or cyclopentyl. The substituted ring structure can comprise substituents including, but not limited to, halides, including fluorine, chlorine and bromine. A preferred compound having a ring structure formed by

R >2 a _Π„ndJ D R3 comprises

The electron withdrawing groups of the present invention are preferably prepared according to Scheme I:

O^^

HCl/MeOH/H₂O

Scheme I

Compounds having Formula I are preferably prepared by the following steps depicted in Scheme I: a) providing an alkylvinylether, b) contacting the alkylvinylether with a strong base to form a first intermediate compound, c) contacting the first intermediate compound with a ketone to form a second intermediate compound, and d) reacting the second intermediate compound with dicyanomethane in the presence of a second base to form an electron withdrawing group portion of a compound having Formula I. Each of the above mentioned steps is described in greater detail below. In preferred embodiments of the invention, an alkylvinylether in a solvent is the starting material. The solvent is, preferably, tetrahydrofuran (THF), 1,4-dioxane, or the like. Although the alkylvinylether depicted in Scheme I is ethylvinylether, other alkylvinylethers can be used. The alkylvinylether preferably comprises the formula CH₃- (CH₂)_x-O-CH=CHR⁶, where x is 1-3 and R⁶ is -C₄ alkyl. Most preferably, the alkylvinylether is methylvinylether or ethylvinylether.

The alkylvinylether is contacted with a strong base to form a first intermediate compound. Preferably, the strong base has a pK_a greater than the ethylinic C-H bond α to the oxygen function of the alkylvinylether. For example, see Advanced Organic Chemistry, Third Ed., Jerry March, 1985, Table 1, pp. 220-222. In preferred embodiments of the invention, the strong base is an alkyl lithium, or an alkali metal salt of an alkyl anion, including, but not limited to, t-BuLi or sec-BuLi. The alkylvinylether is preferably contacted with the strong base between about -70 C and -85 C, most preferably at about -78 C. The first intermediate compound is contacted with a ketone and an acid/alcohol/water solution to form a second intermediate compound. Numerous acid/alcohol/water solutions known to those skilled in the art can be used in the present invention. The acid/alcohol water solution is preferably HCl/MeOH/H₂O,

HBr/EtOH/H₂O, or H₂SO₄ EtOH/H₂O. Preferably, the contacting is at room temperature. Preferably, the pH is adjusted between 1 and 4.

Preferably, the ketone comprises R³-C(=O)R², wherein R² and R³ each, independently, are selected from the group consisting of, substituted and unsubstituted - C₁₀ alkyl, substituted and unsubstituted C o alkenyl, substituted and unsubstituted - Cio alkynyl, substituted and unsubstituted aryl, substituted and unsubstituted alkylaryl, substituted and unsubstituted carbocycle, substituted and unsubstituted heterocycle, substituted and unsubstituted cyclohexyl, and (CH₂)_n-O-(CH2)n where n is 1-10.

"Ci-Cio" refers to Q, C₂, C₃, C₄, C₅, C₆, C , C₈, C₉, C₁₀, and all combinations of ranges thereof. Preferably, the C=C and C≡C bonds of the alkenyl and alkynyl groups are not immediately adjacent or conjugated to the carbonyl group ofthe ketone compound.

The substituted alkyl, alkenyl, alkynyl, carbocyclic, and heterocyclic groups can comprise one or a plurality of substituents including, for example, fluorine, chlorine, D, and the like. In addition, the heterocyclic groups can comprise O, N, S, and the like. The aryl groups preferably include, but are not limited to, benzyl, phenyl, fluorenyl, and naphthyl. The aryl groups, carbocycles, heterocycles, and cyclohexyl can also be substituted by one or a plurality of substituents including, for example, D, halides, including fluorine, chlorine and bromine. The alkylaryl groups preferably comprise Cj-Cio alkyl and the substituted alkylaryl groups comprise the substitutions for the alkyl and aryl groups described above.

and the like.

Alternatively, R² and R³ together form a ring structure or a substituted ring structure from 3 to 7 atoms total with 5 or 6 atoms being preferred. Preferably, the ring structure is substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, or substituted or unsubstituted cyclohexyl or cyclopentyl. The substituted ring structure can comprise substituents including, but not limited to, halides, including fluorine, chlorine and bromine. A preferred compound having a ring structure formed by R² and R³ comprises

The second intermediate compound is reacted with dicyanomethane in the presence of a second base to form the electron withdrawing group portion of a compound having Formula I. The second base is preferably a metal alkoxide including, but not limited to, NaOC₂H₅. After contacting the second intermediate compound with dicyanomethane in the presence of a second base, dilute acid such as, for example, HCI, is added for neutralization of the resultant electron withdrawing group.

The electron withdrawing group comprises R⁶ which is preferably selected from the group consisting of unbranched substituted or unsubstituted - alkyl, unbranched substituted or unsubstituted C₂-C₄ alkenyl, unbranched substituted or unsubstituted C -C alkynyl. The substituted alkyl, alkenyl, and alkynyl groups can comprise one or a plurality of substituents including, for example, fluorine. In preferred embodiments of the invention, R⁶ is selected from the group consisting of unbranched -C alkyl, -C alkenyl, and C₁-C4 alkynyl. In more preferred embodiments of the invention, R⁶ is CH₃. The present invention is also directed, in part, to compounds which can be employed as chromophores in polymeric thin films for optical waveguides wherein the compounds comprise novel bridge groups which couple the electron withdrawing and donating groups of the chromophore. Preferred compounds of the invention have Formula II:

D is an electron donating group. Preferred electron donating groups are described

above.

A is an electron withdrawing group. Preferred electron withdrawing groups are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037,

5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety.

Preferably, A is selected from the group of molecular units containing, but not limited to, nitro, cyano, haloalkyl, acyl, carboxy, aryloxy, carboxamido, alkoxysulfonyl, aryloxysulfonyl, -CH=C(CN)₂, -C(CN)=C(CN)₂, SO₂CF₃, alkanoyloxy,

where X is H, D, F, CN, NO₂, or CF₃. R¹ is -Q-C_nH_2n+1, -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC„F_2n+1,

-Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q preferably is either absent or, when present, O or S; q is 1, 2, or 3. More preferably, R¹ is C₄-Cι₀ or fluorine substituted C₄-Cιo.

A compound having Formula II can be prepared using a thiophene cyclic bridge which preferably comprises Formula Nil:

Preferably, K is O or S.

Preferably, R¹ is -Q-C_nH_2n+1, -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C_nF_2n+ι, -Q-

CH₂SCH₂CC„F_2n+1, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q preferably is either absent or, when present, O or S. Other halogens or deuterium can be used in place of F. In more preferred embodiments of the invention, R¹ is C₄- 0 or fluorine substituted C -Cι₀.

X preferably has the formula -(CH=CH)_b-C(=O)H, where b is 0-3. The terminal aldehyde group serves as the preferred site of reaction with electron withdrawing groups. In more preferred embodiments of the invention, b is 0 so that X is -C(=O)H. Z is a chemical group that is capable of being linked to a donor and includes, but is not limited to, Br, I, -CH₂-Br, -CH₂-OH, -CH₃, -C(=O)H, and the like. Those skilled in the art can use additional groups known to those skilled in the art to couple a bridge compound to a donor. Another Z group that can be used to link a bridge compound to a donor is

Bu

where Y^" is a counter ion including, but not limited to, Br^" or CI^".

In other embodiments of the invention, preferred compounds of the invention have Formula IH:

D is an electron donating group and A is an electron withdrawing group as described above. J is CH₂, O or S.

R¹ is -Q-C_nH_2n+1, -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C„F_2n+1, -Q-CH₂SCH₂CC_nF_2l-_+1. -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S. More preferably, R¹ is C₄-C₁₀ or fluorine substituted C -C₁o.

A compound having Formula IV can be prepared using a dihydronaphthyl cyclic bridge which preferably comprises Formula VIH:

VIII

Preferably, J is CH₂, O or S.

Preferably, R¹ is H, -Q-C_nH_2n+ι. -Q-(CH₂)_aC_nF_2n+ι, -Q-CH₂OCH₂C_nF_2n+1, -Q- CH₂SCH₂CC_nF_2n+ι_. -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S. Other halogens can be used in place of F. In more preferred embodiments of the invention, R¹ is C₄-Cιo or fluorine substituted C₄-Cιo.

X preferably has the formula (C=O)H or C=CH(-CH=CH)_d-C(=O)H, where d is 0-3. The terminal aldehyde or ketone group serves as the preferred site of reaction with electron withdrawing groups. In more preferred embodiments of the invention, X is (C=O)H.

Z is a chemical group that is capable of being linked to a donor, as described above.

The present invention is also directed to compounds which can be employed as chromophores in polymeric thin films for optical waveguides wherein the compounds comprise novel bridge groups and novel electron withdrawing groups, and are represented by Formula IV:

where, K is O or S; and R¹ is -Q-C_nH_2n+ι. -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH2C_nF₂n₊ι, -Q-CH₂SCH₂CC_nF_2n+i, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S, and q is 1, 2, or 3. In more preferred embodiments of the invention, R¹ is C₄-Cιo or fluorine substituted C -Cιo- More preferred compounds of this embodiment of the invention are represented by Formula IV:

(IV) where:

Alternatively, R and R each, independently, are selected from the group consisting of, but not limited to, substituted or unsubstituted CrC₁₀ alkyl, substituted or unsubstituted C2-C₁₀ alkenyl, substituted or unsubstituted C₂-Cιo alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, (CH₂)_n-O-(CH₂)_n where n is 1-10, and the like. More preferably, R² and R³ each, independently, are selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, and substituted or unsubstituted cyclohexyl. More preferably, R² and R³ each, independently, are selected from the group consisting of benzyl, cyclohexyl, and substituted or unsubstituted phenyl. More preferably, one of R² and R³ is CH₃ and the other of R² and R³ is a substituted phenyl. Most preferably, one of R² and R³ is

and the other of R² and R³ is CH₃.

Alternatively, R² and R³ together form a ring structure or a substituted ring structure from 3 to 7 atoms total with 5 or 6 atoms being preferred. Preferably, the ring structure is substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, or substituted or unsubstituted cyclohexyl or cyclopentyl. The substituted ring structure can comprise substituents including, but not limited to, deuterium and halides, including fluorine, chlorine and bromine. A preferred compound having a ring structure formed by R² and R³ comprises

D is an electron donating group as described above.

In other embodiments of the invention, useful compounds are represented by the structure of Formula V:

where, J is CH , O or S.

Preferably, R¹ is -Q-C_nH_2n+1, -Q-(CH₂)_aC_nF_2n+ι, -Q-CH₂OCH₂C_nF_2n+1, -Q-

CH₂SCH₂CC_nF_2n+1, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S. In more preferred embodiments of the invention, R¹ is C4-C10 or fluorine substituted C₄-Cιo. More preferred compounds of this embodiment are represented by the structure of Formula V:

where, R² and R³ are further characterized in that they define a ring in which * denotes a spiro junction, or where * denotes a chiral center.

Alternatively, R² and R³ each, independently, are selected from the group consisting of, but not limited to, substituted or unsubstituted -C₁₀ alkyl, substituted or unsubstituted Qr o alkenyl, substituted or unsubstituted C₂-Cι₀ alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, (CH₂)_n-O-(CH₂)_n where n is 1-10, and the like. More preferably, R² and R³ each, independently, are selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, and substituted or unsubstituted cyclohexyl. ^ More preferably, R and R each, independently, are selected from the group consisting of benzyl, cyclohexyl, and substituted or unsubstituted phenyl. More preferably, one of R² and R³ is CH₃ and the other of R² and R³ is a substituted phenyl. Most preferably, one of R² and R³ is

and the other of R² and R³ is CH₃. Alternatively, R² and R³ together form a ring structure or a substituted ring structure from 3 to 7 atoms total with 5 or 6 atoms being preferred. Preferably, the ring structure is substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, or substituted or unsubstituted cyclohexyl. The substituted ring structure can comprise substituents including, but not limited to, deuterium and halides, including fluorine, chlorine and bromine. A preferred compound having a ring structure formed by R² and R³ comprises

D is an electron donating group as described above.

The present invention is also directed, in part, to optical waveguides comprising polymeric this films having comprising the chromophores of the invention. In preferred embodiments of the invention, optical waveguides comprising a thin film medium have Formula VI:

P and P' are polymer main chain units, which can be the same mer unit or different mer unit, and C is a comonomer unit where n is an integer greater than zero and n' is 0 or an integer greater than zero. Polymers and copolymers that may be employed in the present invention are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety. The polymers of the invention can be a homopolymer or a copolymer. Preferred polymers and copolymers include, but are not limited to, acrylate, vinyl carboxylate, substituted arylvinyl, vinyl halide, vinyl carboxylate, alkene, alkadiene, arylvinyl, methacrylate, vinyl chloride, vinyl acetate, vinyl ether, ethylene, propylene, isobutylene, 1-butene, isoprene, styrene, and the like.

Preferably, the polymers of the invention comprise an external field-induced orientation and alignment of pendant side chains. Preferably, the polymer main chain can be a structural type such as polyvinyl, polyoxyalkylene, polysiloxane, polycondensation, and the like. A polymer can be applied to a supporting substrate by conventional means, such as spin coating, dip coating, spraying, Langmuir-Blodgett deposition, and the like. Thin film optical waveguide medium of the present invention after fabrication can be subjected to an external field to orient and align uniaxially the polymer side chains. In one method the polymer medium is heated close to or above the polymer glass transition temperature T_g, then an external field (e.g., a DC electric field) is applied to the medium of mobile chromophore molecules to induce uniaxial molecular alignment of the chromophore polymer side chains or guests in a guest-host system parallel to the applied field, and the medium is cooled while maintaining the external field effect.

S is a pendant spacer group having a linear chain length of between about 2-12 atoms. Pendant spacer groups that may be employed in the present invention are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509,

4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety.

M is a chromophore compound having Formula I, Formula I', Formula II, Formula IH, Formula IV, Formula IV, Formula V, or Formula V, described above.

The present invention is also directed, in part, to optical devices comprising the optical waveguides of the invention. Optical devices are described in, for example, U.S. Patent Numbers 5,044,725, 4,795,664, 5,247,042, 5,196,509, 4,810,338, 4,936,645, 4,767,169, 5,326,661, 5,187,234, 5,170,461, 5,133,037, 5,106,211, and 5,006,285, each of which is incorporated herein by reference in its entirety. Preferred optical devices include, but are not limited to, laser frequency converters, optical interferometric waveguide gates, wideband electrooptical guided wave analog-to-digital converters, optical parametric devices, and the like, as described in U.S. Pat. No. 4,775,215, which is incorporated herein by reference in its entirety. The invention is further illustrated by way of the following examples which are intended to elucidate the invention. These examples are not intended, nor are they to be construed, as limiting the scope of the disclosure.

EXAMPLES

Example 1: General Synthesis Of Dicyanomethylenedihydrofurans

To a solution of 0.33 mol of ethyl vinyl ether in 150 ml of dry THF, 0.3 mol of t- BuLi in pentane was added dropwise at -78 C. The mixture was stirred and allowed to warm up slowly to 0 C and subsequently cooled to -78 C again. Next, 0.25 mol of cyclohexyl phenyl ketone dissolved in a minimum of dry THF was added dropwise. The mixture was stirred overnight at room temperature, then acidified using HCl MeOH/THF H₂O solution to pH 1-4. After stirring this mixture for two hours, most of the solution was evaporated using a rotary evaporator. The remaining mixture was extracted with ethyl ether (3 x 100 ml). The organic solution was washed with NaHCO₃, brine, and DI water. This mixture was then dried over anhydrous MgSO₄. After evaporating the ether, the crude product was purified by column chromatography (5% ethyl acetate in hexane) to give pure alpha-hydroxy ketone (30 g).

The hydroxy ketone synthesized above (0.02 mol) was mixed with malononitrile (0.04 mol) in ethyl alcohol at 20% w/v based on malononitrile cooled in an ice bath. To this, 20 ml of 1 M NaOC₂H₅ EtOH was added dropwise. The mixture was allowed to stir overnight. After neutralization by concentrated HCI to pH 6, the solvent was evaporated by vacuum. The residue was dissolved into CH₂C1₂ and filtered to remove the undissolved solid. After evaporating the CH₂C1₂, the crude product was purified by recrystalization from ethanol to give the dicyanomethylenedihydrofuran compound (1.25 g). Alternatively, and more preferably, the hydroxy ketone synthesized above (0.02 mol) was mixed with malononitrile (0.04 mol) and potassium carbonate (0.02 mol) in THF

(40 ml) and EtOH (2 ml). To this mixture, a catalytic amount of 18-crown ether was added. The mixture was stirred and allowed to reflux overnight. The solid was filtered off, followed by evaporation of most of the solvent. The crude mixture was purified by column chromatography (CH₂C1₂) to give the dicyanomethylenedihydrofuran compound

(1.5 g) shown below (melting point, MP = 194-196 C).

Example 2: Preparation of a Dicyanomethylenedihydrofuran-based Electron Acceptor

To a solution of ethylvinylether (28.8 g in 300 ml of THF) was added 176 ml of t- BuLi dropwise at -78 C. The mixture was slowly warmed to 0 C and subsequently cooled to -78 C again. Cyclohexanone (30 g in 30 ml of THF) was added dropwise and the "mixture was slowly warmed to room temperature and stirred for an additional four hours. A solution of methanol (70 ml), water (20 ml) and cone. HCI (10 ml) was slowly added to the reaction mixture until a pH of about 2-3 was obtained. The mixture was stirred overnight and neutralized to pH 7 by addition of a 20% solution of NaHCO₃ in water and the solvent was evaporated. The residual solvent was extracted by ether (3 x 100 ml). The ether solution was washed with NaHCO₃ (50 ml), brine (100 ml), and dried over anhydrous MgSO . After removal of the ether, vacuum distillation of the intermediate yielded 36g.

CH₂(CN)₂ (13.2 g) and a 1 M solution of NaOC₂H₅ (0.1 mole) were mixed in an ice bath. Approximately 14.2 g of the intermediate prepared as described above and dissolved in a minimum of EtOH was added dropwise and stirred overnight at room temperature. The mixture was neutralized by 8 ml of cone. HCI to a pH of 6.0 and the solid material was filtered off and the remaining solution was evaporated. The residue from the solution was dissolved into CH₂C1 , filtered again, followed by evaporating the CH₂C1₂. The rest of the mixture was recrystalized from ethanol (150 ml) to give 6.1 g of the final compound shown below (mMP = 239-241 C).

Example 3: Preparation of a Dicyanomethylenedihydrofuran-based Electron Acceptor

To a solution of ethylvinylether (21.6 g in 300 ml of THF) was added 110 ml of t-

BuLi dropwise at -78 C. The mixture was warmed to 0 C and subsequently cooled to -78

C again. 5', 4'-dichloroacetophenone (30.5 g) was dissolved into 150 πύ of THF and then added dropwise. This mixture was run overnight at room temperature. A solution of HCI (10 ml), methanol (70 ml), and water (20 ml) was added to the reaction the next day. The mixture was adjusted to pH 4 and allowed to stir overnight. NaHCO₃ was added to neutralize this solution to pH 7. The mixture was extracted by ether (3 x 100 ml). The combined organic acid mixture was washed with NaHCO₃ (50 ml), brine (100 ml), and dried over anhydrous MgSO₄. Vacuum distillation of the intermediate yielded 55 g. CH₂(CN)₂ (13.2 g) and a 1 M solution of NaOC₂H₅ (0.1 mole) were mixed in an ice bath. Approximately 15 g of the intermediate prepared as described above and dissolved in EtOH was added dropwise and stirred overnight at room temperature. The mixture was neutralized by 8 ml of cone. HCL to a pH of 6.0 and the solid material was filtered and the resulting solution evaporated. The residue was dissolved into CH₂C1₂, filtered again, followed by evaporating the CH₂C1₂. The rest of the mixture was recrystalized from ethanol (150 ml) to give 5.5 g of the final compound shown below (MP = 110-111 C; 152-153 C; and 222-224 C, respectively left to right).

Example 4: Preparation of trans-[(N,N-di(2-ethanoI)amino)phenylene-3-decanyl-2- thiophene]

To a solution of 3-decanyl-2-methyltributylphosphonium-thiophene bromide (26 g, 0.05 mol) and N,N-di-ethanol aminophenyl aldehyde (12.6 g, 0.06 mol) in 200 ml of ethanol, NaOC₂H₅ (1 M in ethanol) was added dropwise. The resulting mixture was refluxed for 98 hours. After removal of this reaction from the bath oil, the solvent was evaporated, and the residue was extracted with ethyl ether (3 x 150 ml). The combined ether mixture was washed with water (100 ml), brine (2 x 100 ml) and dried over anhydrous MgSO₄. After removal of the solvent, the residue was purified by column chromatography on silica and eluted using 50% ethyl acetate, 10% acetone, and 40% hexane to give the pure title compound with a yield of 16 g. Carbon and proton NMR were consistent with the structure.

Example 5: Preparation of trans-[(N,N-di(2-ethanol)amino)phenylene-2-thiene-3- 5 decanyl-5-al]

To a 500 ml flask with the compound synthesized above (10.44 g, 0.0243 mol),

200 ml of THF was added. The solution was cooled to -78 C and n-BuLi (32 ml, 2.5 M in hexane) was added dropwise. The mixture was stirred for 2 hours followed by addition of

10 DMF (6 ml). The resulting solution was stirred overnight at room temperature. After adding HCI (2 M, 50 ml) and stirring for an hour, the THF was evaporated. The residue was extracted with ethyl ether (3 x 100 ml). The combined organic solution was washed with saturated Na₂CO₃ solution (50 ml), water (100 ml), brine (100 ml) and dried over anhydrous MgSO₄. After evaporating the solvent, solid target compound (11.1 g, mp 107-

15 109 C) was obtained. HNMR showed that this compound was pure enough for the next step.

Example 6: Preparation of Chromophore

The above aldehyde compound (3 g, 6.54 mmol) and 2-dicyanomethylen-3- 0 cyano-4,5-dimethyl-5-(3,4-dichlorophenyl)-2,5-dihydrofuran (2.4 g, 7.27 mmol) were mixed and dissolved in EtOH (30 ml). Two or three drops of piperidine were added. The mixture was refluxed for 48 hours. After cooling, the precipitated solid was filtered, recrystalized from EtOH, and purified by chromatography silica elution solvent to give 3.38 g of the chromophore. Carbon and proton NMR were performed and analysis thereof 5 was consistent with the structure. Example 7: Preparation of Chromophore

Trans-[(N,N-di(2-ethanol)amino)phenylene-3,4-dibutyl-2-thiophene-5-al] (0.3 g, 0.7 mmol) is mixed with 2-dicyanomethylen-3-cyano-4,5-dimethyl-5-(3,4- dichlorophenyl)-2,5-dihydrofurane (0.23 g, 0.7 mmol) in EtOH (20 ml). Two or three drops of piperidine is added. The mixture is refluxed for 48 hours. After cooling, the precipitated solid is filtered, recrystalized from EtOH, and purified by chromatography silica elution solvent.

Example 8: Preparation of Highly Chlorinated Electro-Optic Polymer To a three-neck flask with l,4,5,6JJ-hexchloro-5-norbornene-2,3-dicarboxylic acid chloride (2.65 g, 6.23 mmol) and 2,3,5,6-tetrachloro-p-xylene-αα-diol (1.36 g, 4.93 mmol), 2-dicyanomethylen-3-cyano-4-{2-[E-(4-N,N-di-(2-ethanol)amino)phenylene-(3- decanyl)thien-5]-E-vinyl}-5-methyl-5-(3,4-dichlorophenyl)-2,5-dihydrofuran (1 g, 1.3 mmol) were mixed in 20 ml THF at 70 C. Et₃N (1.26 g in 15 ml THF) was added dropwise. The mixture was refluxed under Ar for 48 hours. After evaporating some of the THF, the rest of the solution was slowly dropped into MeOH (300 ml) and water (50 ml) with violent stirring. The precipitated solid was filtered, redissolved in THF and precipitated again in MeOH (300 ml). The collected solid was vacuum dried for 8 hours and weighed 4.5 g. The polymer was characterized by DSC and TGA. The T_g is 152 C, and the decomposing temperature under air is 285 C.

Although the invention has been described in detail for the purpose of illustration, it is understood that such detail is solely for that purpose, and variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention which is defined by the following claims.

Claims

WHAT IS CLAIMED IS:

A compound having Formula II

wherein: K is O or S;

D is an electron donating group; A is an electron accepting group;

R¹ is -Q-C_nH_2n+ι. -Q-(CH₂)_aC_nF2„₊ι, -Q-CH₂OCH₂C_nF_2n+ι, -Q-CH₂SCH₂CC_nF_2n+1, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; and q is 1, 2, or 3.

A compound having Formula IH

wherein:

J is CH₂, O or S;

D is an electron donating group;

A is an electron accepting group; and R , ι¹ is -Q-C_nH_2n+ι. -Q-(CH₂)_aC_nF_2n+_, -Q-CH2OCH₂C_nF2„₊i, -Q-CH₂SCH₂CC_nF_2n+1, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S.

3. The compound of claims 1 or 2 wherein A comprises a molecular unit selected from the group consisting of nitro, cyano, haloalkyl, acyl, carboxy, aryloxy, carboxamido, alkoxysulfonyl, aryloxysulfonyl, -CH=C(CN)₂, -C(CN)=C(CN)₂, SO₂CF₃, alkanoyloxy,

where X is H, D, F, CN, NO₂, or CF₃.

4. The compound of claim 3 wherein a is 1-3 and n is 1-3.

The compound of claim 4 wherein R¹ is C₄-Cι₀ or fluorine substituted C₄-CIQ.

A compound having Formula I':

where: R² and R³ define a ring structure or substituted ring structure in which * denotes a spiro junction, or where * denotes a chiral center; or R² and R³ each, independently, are either substituted or unsubstituted Ci-Cio alkyl, substituted or unsubstituted C₂-Cιo alkenyl, substituted or unsubstituted C₂-C,o alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocyclic, substituted or unsubstituted heterocyclic, substituted or unsubstituted cyclohexyl, or (CH₂)_n-O-(CH₂)_n, where n is 1-10; provided that when R and R are both selected from substituted or

unsubstituted C C₁₀ alkyl, R² ≠ R³;

D is an electron donating group; and

B comprises at least one bivalent aromatic ring.

7. The compound of claim 6 wherein B is selected from the group consisting of

where R⁴ is H, OH, -Cio alkyl, alkenyl, alkynyl, or halogen. 9

8. The compound of claim 7 wherein R and R each, independently, are selected from the group consisting of, substituted or unsubstituted - o alkyl, substituted or unsubstituted C₂-Cιo alkenyl, substituted or unsubstituted C₂-Cιo alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH₂)_n where n is 1-10, provided that when R² and R³ are both selected from substituted or unsubstituted -Cio alkyl, R² ≠ R³.

9. The compound of claim 8 wherein R² and R³ each, independently, are selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, and substituted or unsubstituted cyclohexyl.

10. A compound having Formula IV

(IV) where:

R² and R³ define a substituted or unsubstituted ring structure in which * denotes a spiro junction, or where * denotes a chiral center; or R² and R³ each, independently, are selected from the group consisting of substituted or unsubstituted -Cio alkyl, substituted or unsubstituted C₂-C₁₀ alkenyl, substituted or unsubstituted C₂-Cιo alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH₂)_n where n is 1-10;

D is an electron donating group; K is O or S;

R¹ is -Q-C_nH_2n+ι, -Q-(CH₂)_aC_nF_2n+1, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC_nF_2n+1, -Q-CH₂OCH₂CF₃, or -Q-CH₂SCH₂CF₃, where n is 1-10, a is 0-10, and Q is absent, O or S; and q is 1, 2, or 3.

9 ^

11. The compound of claim 10 wherein R and R each, independently, are selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, and substituted or unsubstituted cyclohexyl or cyclopentyl.

12. A compound having Formula V

(V ) where: R² and R³ define a substituted or unsubstituted ring structure in which * denotes a

9 spiro junction, or where * denotes a chiral center; or R and R each, independently, are selected from the group consisting of substituted or unsubstituted Ci-Cio alkyl, substituted or unsubstituted - o alkenyl, substituted or unsubstituted C₂-Cι₀ alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH2)_n where n is 1-10;

D is an electron donating group;

J is CH₂, O or S; and R¹ is -Q-C_nH_2n+ι, -Q-(CH₂)_aC„F_2n+1, -Q-CH₂OCH₂C_nF_2n+1, -Q-CH₂SCH₂CC_nF_{2n+1 >}

13. The compound of claim 12 wherein R and R each, independently, are selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, and substituted or unsubstituted cyclohexyl.

14. The compound of any one of claims 1, 2, 6, 10 or 12 wherein D is a phenyl ring substituted at the para position by a moiety selected from the group consisting of amino, alkylamino, dialkylamino, dialkylanilino, 1-piperidino, 1-piperazino, 1-pyrrolidino, acylamino, hydroxyl, thiolo, alkylthio, arylthio, alkoxy, aryloxy, acyloxy, alkyl, vinyl, and 1 ,2,3 ,4-tetrahydroquinolinyl.

15. The compound of any one of claims 6, 10 or 12 wherein R² and R³ each, independently, are selected from the group consisting of benzyl, cyclohexyl, cyclopentyl, and substituted or unsubstituted phenyl.

16. The compound of any one of claims 6, 10 or 12 wherein one of R² and R³ is CH₃ and the other of R² and R³ is a substituted phenyl.

17. The compound of claim 16 wherein the substituted phenyl is

18. The compound of any one of claims 6, 10 or 12 wherein R² and R³ are different and are both selected from the group consisting of substituted and unsubstituted Ci-Cio alkyl.

19. The compound of any one of claims 6, 10 or 12 wherein R² and R³ together form a ring structure or a substituted ring structure.

20. The compound of claim 19 wherein R² and R³ together form cyclohexyl or cyclopentyl.

21. The compound of claim 10 or 12 wherein R and R^J each, independently, are selected from the group consisting of, substituted or unsubstituted Ci-Cio alkyl, substituted or unsubstituted C₂-Cιo alkenyl, substituted or unsubstituted C₂-Cιo alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted 5 carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH₂)_n where n is 1-10.

22. The compound of claim 10 or 12 wherein a is 1-3 and n is 1-3.

10 23. The compound of claim 10 or 12 wherein R¹ is - o or fluorine substituted C -

Cio-

24. An optical waveguide comprising a thin film medium having Formula VI

VI

15 wherein:

P and P' are polymer main chain units;

C is a comonomer unit;

S is a pendant spacer group having a linear chain length of between about 2-12 atoms; 0 n is an integer greater than zero; n' is 0 or an integer greater than zero; and M is a compound of any one of claims 1 to 23.

25. An optical device comprising the optical waveguide of claim 24.

26. The optical device of claim 25 wherein said device is selected from the group consisting of a laser frequency converter, an optical interferometric waveguide gate, a wideband electrooptical guided wave analog-to-digital converter, and an optical parametric device.

27. A method of preparing an electron withdrawing group comprising the steps:

(a) providing an alkylvinylether;

(b) contacting said alkylvinylether with a strong base to form a first intermediate compound;

(c) contacting said first intermediate compound with a ketone to form a second intermediate compound; and

(d) reacting said second intermediate compound with dicyanomethane in the presence of a second base to form said electron withdrawing group.

28. The method of claim 27 wherein said alkylvinylether is in a solvent.

29. The method of claim 28 wherein said solvent is tetrahydrofuran or 1 ,4-dioxane.

30. The method of 29 wherein said alkylvinylether comprises the formula CH₃- (CH₂)_x-O-CH=CHR⁶, where x is 1-3 and R⁶ is H or d-C₄ alkyl.

31. The method of claim 30 wherein said alkylvinylether is methylvinylether or

ethylvinylether.

32. The method of claim 27 wherein said strong base has a pK_a greater than the ethylinic C-H bond α to the oxygen function of said alkylvinylether.

33. The method of claim 32 wherein said strong base is an alkyl lithium.

34. The method of claim 33 wherein said alkyl lithium is t-BuLi or sec-BuLi.

35. The method of claim 27 wherein said ketone comprises the formula R³-C(=O)R², wherein R² and R³ each, independently, are selected from the group consisting of, substituted or unsubstituted Ci- o alkyl, substituted or unsubstituted C₂-Cιo alkenyl, substituted or unsubstituted C₂-Cιo alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkylaryl, substituted or unsubstituted carbocycle, substituted or unsubstituted heterocycle, substituted or unsubstituted cyclohexyl, and (CH₂)_n-O-(CH₂)_n where n is 1-10.

36. The method of claim 35 wherein said R² and R³ each, independently, are selected from the group consisting of benzyl, cyclohexyl, cyclopentyl, phenyl, and substituted

phenyl.

37. The method of claim 36 wherein one of said R² and R³ is CH₃ and the other of R² and R³ is a substituted phenyl.

38. The method of claim 27 wherein said second base is a metal alkoxide.

39. The method of claim 38 wherein said metal alkoxide is NaOC₂H₅.